Skip to content
StockMarketAgent
Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

LON/0QQM stock hub

LON/0QQM has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

LON/0QQMis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
296.7M
London Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
LON/0QQM
In the news

Latest news · LON/0QQM

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.9P50 16.9P75 23.5
Trailing P/E17.3
P25 15.9P50 22.9P75 35.8
ROE11.9
P25 -54.2P50 2.1P75 13.7
ROIC40.3
P25 -38.1P50 3.3P75 11.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All LON/0QQM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
225
Groups with data
11
Currency
CHF
Showing 225 of 225 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Switzerland
Country code
UK
Employees
279
Employees Change
9%
Employees Change Percent
3.33
Enterprise value
CHF 191.9M
Exchange
London Stock Exchange
Financial currency
CHF
First seen
2026-05-10
Industry
Medical Instruments & Supplies
Isin
CH0187624256
Last refreshed
2026-05-10
Market cap
CHF 296.7M
Price
CHF 133
Price currency
CHF
Rev Per Employee
543,575.11x
Sector
Healthcare
Sic
3842
Symbol
lon/0QQM
Website
https://www.ivf.hartmann.info

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
5.78%
EV Earnings
11.2x
EV/EBIT
9.7x
EV/EBITDA
8.17x
EV/FCF
11.56x
EV/Sales
1.26x
FCF yield
5.6%
P/B ratio
2.04x
P/E ratio
17.31x
P/S ratio
1.96x
PE Ratio10 Y
24.43x
PE Ratio3 Y
18.04x
PE Ratio5 Y
18.31x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

26
MetricValue
EBIT Margin
12.95%
EBITDA Margin
15.38%
FCF margin
10.95%
Gross margin
55.49%
Gross Profit
CHF 84.2M
Gross Profit Growth
0.84%
Gross Profit Growth Q
1.62%
Gross Profit Growth3 Y
1.94%
Gross Profit Growth5 Y
2.17%
Net Income
CHF 17.1M
Net Income Growth
-9.89%
Net Income Growth Q
-6.73%
Net Income Growth Years
0%
Net Income Growth3 Y
1.23%
Net Income Growth5 Y
6.71%
Pretax Margin
13.22%
Profit Margin
11.3%
Profit Per Employee
CHF 61,439
Profitable Years
14
ROA
6.8
Roa5y
5.45
ROCE
13.14
ROE
11.9
Roe5y
9.61
ROIC
40.34
Roic5y
21.98

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

26
MetricValue
Cagr1y
-7.57%
Cagr3y
10.71%
Cagr5y
3.44%
Div CAGR10
8.05%
Div CAGR3
17.01%
Div CAGR5
5.4%
EPS Growth
-9.93
EPS Growth Q
-6.66
EPS Growth Years
0
EPS Growth3 Y
1.21
EPS Growth5 Y
6.7
FCF Growth
-2.49%
FCF Growth Q
22.25%
FCF Growth3 Y
-15.79%
FCF Growth5 Y
-0.19%
OCF Growth
5.19%
OCF Growth Q
22.58%
OCF Growth10 Y
-3.58%
OCF Growth3 Y
-11.88%
OCF Growth5 Y
1.41%
Revenue Growth
1.77x
Revenue Growth Q
2.63x
Revenue Growth Quarters
4x
Revenue Growth Years
2x
Revenue Growth3 Y
1.84x
Revenue Growth5 Y
1.56x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
CHF 0.84
Assets
CHF 183.7M
Cash
CHF 104.7M
Current Assets
CHF 149.9M
Current Liabilities
CHF 34.5M
Debt
CHF 700,882
Debt EBITDA
CHF 0.03
Debt Equity
CHF 0
Debt FCF
CHF 0.04
Equity
CHF 145.6M
Interest Coverage
635.1
Liabilities
CHF 38.1M
Long Term Assets
CHF 33.8M
Long Term Liabilities
CHF 3.6M
Net Cash
CHF 104M
Net Cash By Market Cap
CHF 35.06
Net Cash Growth
2.62%
Net Debt EBITDA
CHF -4.46
Net Debt Equity
CHF -0.71
Net Debt FCF
CHF -6.26
Tangible Book Value
CHF 144.7M
Tangible Book Value Per Share
CHF 60.74
WACC
6.73

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
4.34
Inventory Turnover
3.35
Net Working Capital
CHF 9.8M
Quick ratio
3.73
Working Capital
CHF 114.5M
Working Capital Turnover
CHF 1.26

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-0.04%
Dividend Growth
-37.25%
Dividend Growth Years
0%
Dividend per share
CHF 3.58
Dividend Years
13
Dividend Yield
2.64%
Ex Div Date
2026-04-16
Last Dividend
CHF 3.58
Payout Frequency
Annual
Payout Ratio
81.34%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
1Y total return
-7.57%
200-day SMA
140.3
3Y total return
35.71%
50-day SMA
140.6
50-day SMA vs 200-day SMA
50over200
5Y total return
18.41%
All Time High
203.4
All Time High Change
-34.86%
All Time High Date
2017-09-07
All Time Low
105
All Time Low Change
26.19%
All Time Low Date
2024-01-05
ATR
2.21
Beta
0.45
Ch YTD
-4.68
High
135.5
High52
150
High52 Date
2026-02-03
High52ch
-11.67%
Low
132.5
Low52
132
Low52 Date
2026-05-06
Low52ch
0.38%
Ma50ch
-5.76%
Price vs 200-day SMA
-5.57%
RSI
41.98
RSI Monthly
42.5
RSI Weekly
41.05
Sharpe ratio
0.05x
Sortino ratio
0.2
Total Return
2.6%
Tr YTD
-1.92
Tr1m
-2.27%
Tr1w
-1.49%
Tr3m
-6.62%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
CHF 19.6M
Operating Income Growth
-4.94
Operating Income Growth Q
-8.65
Operating Income Growth3 Y
2.71
Operating Income Growth5 Y
6.88
Operating margin
12.95

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

3
MetricValue
Shares Institutions
1.37%
Shares Qo Q
-0.2%
Shares Yo Y
0.04%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

57
MetricValue
Adjusted FCF
CHF 16.6M
Average Volume
2.7x
Bv Per Share
61.15
CAPEX
CHF -3.5M
Ch1m
-5.02
Ch1w
-1.49
Ch1y
-10.17
Ch3m
-9.25
Ch3y
16.74
Ch5y
-3.99
Ch6m
-1.49
Change
-1.85%
Change From Open
-2.21
Close
135
Days Gap
0.37
Depreciation Amortization
3,722,539.5
Earnings Date
2026-06-12
EBIT
CHF 19.6M
EBITDA
CHF 23.3M
EPS
CHF 7.14
F Score
4
FCF
CHF 16.6M
FCF EV Yield
8.65x
Financing CF
-13,942,670
Fiscal Year End
December
Founded
1,870
Graham Number
105.83726
Graham Upside
-20.12
Income Tax
CHF 2.9M
Investing CF
-9,136,759
Is Primary Listing
0
Last Earnings Date
2026-03-02
Last Report Date
2025-12-31
Lynch Fair Value
CHF 51.36
Lynch Upside
-61.24
Ma150
142.9
Ma150ch
-7.26%
Ma20
135.8
Ma20ch
-2.43%
Net CF
-2,971,250
Next Earnings Date
2026-06-12
Open
135.5
P FCF Ratio
17.87
P OCF Ratio
14.76
Payment Date
2026-04-20
Position In Range
0
Ppne
32,196,237.8
Price Date
2026-05-08
Price EBITDA
CHF 12.72
Ptbv Ratio
2.05
Relative Volume
94.88x
Revenue
151,657,455x
Tax By Revenue
1.92x
Tax Rate
14.52%
Tr6m
1.37%
Volume
0
Z Score
7.99
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

LON/0QQM dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+2.6%
$3.58 annual per share
Payout ratio
+81.3%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+5.4%
0 consecutive years of growth
Total shareholder yield
+2.6%
Next ex-dividend date: 2026-04-16
Performance

LON/0QQM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-7.6%
S&P 500 1Y: n/a
3Y total return
+35.7%
S&P 500 3Y: n/a
5Y total return
+18.4%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns LON/0QQM?

Insider, institutional, and short-interest positioning.

Institutional ownership
+1.4%
Share of float held by funds and institutions
Insider ownership
n/a
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.0%
Negative means the company is buying back shares.
Technical

LON/0QQM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
42.0
Neutral momentum band
Price vs 200-day MA
-5.6%
50/200-day relationship not available
Beta (5Y)
0.45
Less volatile than the market
Sharpe ratio
0.05
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About LON/0QQM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0QQM stock rating?

lon/0QQM is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0QQM analysis?

The full report lives at /stocks/lon/0QQM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0QQM?

The latest report frames lon/0QQM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0QQM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

lon/0QQM stock profile: metrics, valuation and analysis | 株式市場AIエージェント